{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T17:40:05Z","timestamp":1752255605813,"version":"3.41.2"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,11]]},"DOI":"10.7759\/cureus.87736","type":"journal-article","created":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T17:13:26Z","timestamp":1752254006000},"source":"Crossref","is-referenced-by-count":0,"title":["Diagnosis and Treatment of Plasmablastic Lymphoma in an Immunocompetent Patient: A Report of a Rare Case"],"prefix":"10.7759","author":[{"given":"Pyrus","family":"Bhellum","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajat","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satyendra","family":"Khichar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikarn","family":"Vishwajeet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harshita","family":"Yalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-10-567479","article-title":"The biology and treatment of plasmablastic lymphoma","volume":"125","author":"Castillo JJ","year":"2015","unstructured":"Castillo JJ, Bibas M, Miranda RN. The biology and treatment of plasmablastic lymphoma. Blood. 2015, 125:2323-30. 10.1182\/blood-2014-10-567479","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.4.1413","article-title":"Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection","volume":"89","author":"Delecluse HJ","year":"1997","unstructured":"Delecluse HJ, Anagnostopoulos I, Dallenbach F, et al.. Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood. 1997, 89:1413-20. 10.1182\/blood.V89.4.1413","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000234","article-title":"Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases","volume":"38","author":"Morscio J","year":"2014","unstructured":"Morscio J, Dierickx D, Nijs J, et al.. Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases. Am J Surg Pathol. 2014, 38:875-86. 10.1097\/PAS.0000000000000234","journal-title":"Am J Surg Pathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2011.03.008","article-title":"HIV-negative plasmablastic lymphoma: not in the mouth","volume":"11","author":"Castillo JJ","year":"2011","unstructured":"Castillo JJ, Winer ES, Stachurski D, et al.. HIV-negative plasmablastic lymphoma: not in the mouth. Clin Lymphoma Myeloma Leuk. 2011, 11:185-9. 10.1016\/j.clml.2011.03.008","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.4103\/0019-509X.204756","article-title":"Plasmablastic lymphoma of the gastrointestinal tract: a rare entity with a dismal prognosis","volume":"53","author":"Komaranchath AS","year":"2016","unstructured":"Komaranchath AS, Haleshappa RA, Kuntegowdenahalli LC, Kumar RV, Dasappa L, Babu G. Plasmablastic lymphoma of the gastrointestinal tract: a rare entity with a dismal prognosis. Indian J Cancer. 2016, 53:529-33. 10.4103\/0019-509X.204756","journal-title":"Indian J Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.5045\/br.2020.55.1.49","article-title":"HIV-negative plasmablastic lymphoma: report of 8 cases and a comprehensive review of 394 published cases","volume":"55","author":"Li YJ","year":"2020","unstructured":"Li YJ, Li JW, Chen KL, et al.. HIV-negative plasmablastic lymphoma: report of 8 cases and a comprehensive review of 394 published cases. Blood Res. 2020, 55:49-56. 10.5045\/br.2020.55.1.49","journal-title":"Blood Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow SH","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, et al.. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016, 127:2375-90. 10.1182\/blood-2016-01-643569","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw684","article-title":"Clinical characteristics and prognostic factors of plasmablastic lymphoma patients: analysis of 135 patients from the LYSA group","volume":"28","author":"Tchernonog E","year":"2017","unstructured":"Tchernonog E, Faurie P, Coppo P, et al.. Clinical characteristics and prognostic factors of plasmablastic lymphoma patients: analysis of 135 patients from the LYSA group. Ann Oncol. 2017, 28:843-8. 10.1093\/annonc\/mdw684","journal-title":"Ann Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2010.516040","article-title":"Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma","volume":"51","author":"Castillo JJ","year":"2010","unstructured":"Castillo JJ, Winer ES, Stachurski D, et al.. Clinical and pathological differences between human immunodeficiency virus-positive and human immunodeficiency virus-negative patients with plasmablastic lymphoma. Leuk Lymphoma. 2010, 51:2047-53. 10.3109\/10428194.2010.516040","journal-title":"Leuk Lymphoma"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.15406\/htij.2018.06.00146","article-title":"Plasmablastic myeloma versus plasmablastic lymphoma: different yet related diseases","volume":"6","author":"Morris A","year":"2018","unstructured":"Morris A, Monohan G. Plasmablastic myeloma versus plasmablastic lymphoma: different yet related diseases. Hematol Transfus Int J. 2018, 6:25-8. 10.15406\/htij.2018.06.00146","journal-title":"Hematol Transfus Int J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800355","article-title":"Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles","volume":"18","author":"Vega F","year":"2005","unstructured":"Vega F, Chang CC, Medeiros LJ, et al.. Plasmablastic lymphomas and plasmablastic plasma cell myelomas have nearly identical immunophenotypic profiles. Mod Pathol. 2005, 18:806-15. 10.1038\/modpathol.3800355","journal-title":"Mod Pathol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7150\/jca.51027","article-title":"Clinical characteristics and outcomes in HIV-associated diffuse large B-cell lymphoma in China: a retrospective single-center study","volume":"12","author":"Wu J","year":"2021","unstructured":"Wu J, Miao Y, Qian C, et al.. Clinical characteristics and outcomes in HIV-associated diffuse large B-cell lymphoma in China: a retrospective single-center study. J Cancer. 2021, 12:2903-11. 10.7150\/jca.51027","journal-title":"J Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-025-01636-9","article-title":"Meta-analysis of the comparative efficacy and safety of new drugs in combination with chemotherapy in primary plasmoblastic lymphoma","volume":"25","author":"Guo B","year":"2025","unstructured":"Guo B, Quan X, Yang Z, Li J, Liu Y. Meta-analysis of the comparative efficacy and safety of new drugs in combination with chemotherapy in primary plasmoblastic lymphoma. Clin Exp Med. 2025, 25:103. 10.1007\/s10238-025-01636-9","journal-title":"Clin Exp Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.336","article-title":"Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group","volume":"27","author":"Fern\u00e1ndez de Larrea C","year":"2013","unstructured":"Fern\u00e1ndez de Larrea C, Kyle RA, Durie BG, et al.. Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group. Leukemia. 2013, 27:780-91. 10.1038\/leu.2012.336","journal-title":"Leukemia"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/385382-diagnosis-and-treatment-of-plasmablastic-lymphoma-in-an-immunocompetent-patient-a-report-of-a-rare-case","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,11]],"date-time":"2025-07-11T17:13:26Z","timestamp":1752254006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/385382-diagnosis-and-treatment-of-plasmablastic-lymphoma-in-an-immunocompetent-patient-a-report-of-a-rare-case"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,11]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.87736","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,11]]}}}